Breast Cancer Research and Treatment

MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells
pp. 253-261(9)
Authors: Nilsson, Ulrika; Garvin, Stina; Dabrosin, Charlotta

15-Deoxy-Δ^12,14-prostaglandin J₂ inhibits G₂-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression
pp. 263-273(11)
Authors: Kamagata, Chinatsu; Tsuji, Naoki; Moriai, Mikako; Kobayashi, Daisuke; Watanabe, Naoki

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib
pp. 275-282(8)
Authors: Maiello, Monica; D'Alessio, Amelia; Luca, Antonella; Carotenuto, Adele; Rachiglio, Anna; Napolitano, Maria; Cito, Letizia; Guzzo, Antonella; Normanno, Nicola

Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients
pp. 283-288(6)
Authors: Lee, Seeyoun; Kim, Eun; Kang, Seok; Kim, Seok; Kim, Seok-Ki; Kang, Keon; Kwon, Youngmee; Shin, Kyung; Kang, Han-Sung; Ro, Jungsil; Lee, Eun

Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2-3 years treatment with tamoxifen in Sweden
pp. 289-299(11)
Authors: Lundkvist, Jonas; Wilking, Nils; Holmberg, Stig; Jönsson, Linus

Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer
pp. 301-312(12)
Authors: Gordon, N.; Silverman, P.; Lasheen, W.; Meinert, J.; Siminoff, L.

Pectoral stretching program for women undergoing radiotherapy for breast cancer
pp. 313-321(9)
Authors: Lee, T.S.; Kilbreath, S.L.; Refshauge, K.M.; Pendlebury, S.C.; Beith, J.M.; Lee, M.J.

Changes in risk of death from breast cancer with season and latitude: Sun exposure and breast cancer survival in Norway
pp. 323-328(6)
Authors: Porojnicu, Alina; Lagunova, Zoya; Robsahm, Trude; Berg, Jens; Dahlback, Arne; Moan, Johan

Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis
pp. 329-337(9)
Authors: Huo, Xiang; Hu, Zhibin; Zhai, Xiangjun; Wang, Yan; Wang, Shui; Wang, Xuechen; Qin, Jianwei; Chen, Wenseng; Jin, Guangfu; Liu, Jiyong; Gao, Jun; Wei, Qingyi; Wang, Xinru; Shen, Hongbing

The association between the pre-diagnosis mammography screening interval and advanced breast cancer
pp. 339-345(7)
Authors: Goel, Anupam; Littenberg, Benjamin; Burack, Robert

Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?
pp. 347-356(10)
Authors: Shen, Yu; Dong, Wenli; Esteva, Francisco; Kau, Shu-Wan; Theriault, Richard; Bevers, Therese

Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
pp. 357-363(7)
Authors: Kriege, M.; Brekelmans, C.; Peterse, H.; Obdeijn, I.; Boetes, C.; Zonderland, H.; Muller, S.; Kok, T.; Manoliu, R.; Besnard, A.; Tilanus-Linthorst, M.; Seynaeve, C.; Bartels, C.; Meijer, S.; Oosterwijk, J.; Hoogerbrugge, N.; Tollenaar, R.; Koning, H.; Rutgers, E.; Klijn, J.

Reproductive factors and breast cancer risk among older women
pp. 365-374(10)
Authors: Shantakumar, Sumitra; Terry, Mary; Teitelbaum, Susan; Britton, Julie; Millikan, Robert; Moorman, Patricia; Neugut, Alfred; Gammon, Marilie

Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer
pp. 375-381(7)
Authors: Bartsch, Rupert; Wenzel, Catharina; Altorjai, Gabriela; Pluschnig, Ursula; Bachleitner-Hoffmann, Thomas; Locker, Gottfried; Rudas, Margaretha; Mader, Robert; Zielinski, Christoph; Steger, Guenther